Clinical trial
Energy Homeostasis Under Treatment With Atypical Antipsychotics
NCT00148564 · Charite University, Berlin, Germany, Other · Completed
Key facts
| NCT number | NCT00148564 |
|---|---|
| Title | Energy Homeostasis Under Treatment With Atypical Antipsychotics |
| Official title | Energy Homeostasis and Metabolism in Patients With Schizophrenic Disorders Under Treatment With Atypical Antipsychotics |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | olanzapine, Ziprasidone |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Sep 29, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: